Pros and cons of etomidate - More discussion than evidence?

Current Opinion in Anaesthesiology

Volumn 26, Issue 4, 2013, Pages 404-408

  Van Den Heuvel, Ingeborg ^a   Wurmb, Thomas E ^b   Böttiger, Bernd W ^c   Bernhard, Michael ^d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

adrenocortical insufficiency; anesthesia; critically ill; etomidate; sepsis; trauma

Indexed keywords

CATECHOLAMINE; ETOMIDATE; HYDROCORTISONE; IMIDAZOLE; KETAMINE; LIPID EMULSION; OPIATE; PROPOFOL; STEROID; THIOPENTAL; THROMBOXANE;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ANESTHESIA INDUCTION; BRAIN BLOOD FLOW; BRONCHUS REACTIVITY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; DRUG METABOLISM; DRUG SAFETY; EMERGENCY CARE; ENDOTRACHEAL INTUBATION; EVIDENCE BASED PRACTICE; HEMODYNAMICS; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTENSION; INJURY; INTRACRANIAL PRESSURE; LIVER BLOOD FLOW; LUNG RESISTANCE; META ANALYSIS (TOPIC); MORTALITY; MULTIPLE TRAUMA; MYOCLONUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INTUBATION; RETROSPECTIVE STUDY; REVIEW; SEPTIC SHOCK; STEROIDOGENESIS; TRAUMATIC BRAIN INJURY;

ETOMIDATE; HEMODYNAMICS; HUMANS; HYDROCORTISONE; HYPNOTICS AND SEDATIVES; SEPSIS;

EID: 84880835124     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328362a84c     Document Type: Review

References (27)

1. Ray DC, McKeown DW. Etomidate for critically ill patients. Pro: yes we can use it. Eur J Anaesthesiol 2012; 29:506-510.
2. de la Grandville B, Arroyo D, Walder B. Etomidate for critically ill patients. Con: do you really want to weaken the frail? Eur J Anaesthesiol 2012; 29:511-514.
3. Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011; 114:695-707
4. Moller Petrun A, Kamenik M. Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial. Br J Anaesth 2013; 110:388-396.
5. Budde AO, Mets B. Pro: etomidate is the ideal induction agent for a cardiac anesthetic. J Cardiothorac Vasc Anesth 2013; 27:180-183.
6. Malhotra AK. Con: etomidate-the ideal induction agent for a cardiac anesthetic? J Cardiothorac Vasc Anesth 2013; 27:178-179.
7. Bignami E, Greco T, Barile L, et al. The effect of isoflurane on survival and myocardial infarction: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2013; 27:50-58.
8. Bein B. Clinical application of the cardioprotective effects of volatile anaesthetics: PRO-get an extra benefit from a proven anaesthetic free of charge. Eur J Anaesthesiol 2011; 28:620-622.
9. Van Rompaey N, Barvais L. Clinical application of the cardioprotective effects of volatile anaesthetics: CON-total intravenous anaesthesia or not total intravenous anaesthesia to anaesthetise a cardiac patient? Eur J Anaesthesiol 2011; 28:623-627.
10. Archambault P, Dionne CE, Lortie G, et al. Adrenal inhibition following a single dose of etomidate in intubated traumatic brain injury victims. CJEM 2012; 14:270-282.
11. Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 2011; 305:1201-1209.
12. Asehnoune K, Mahe PJ, Seguin P, et al. Etomidate increases susceptibility to pneumonia in trauma patients. Intensive Care Med 2012; 38:1673-1682.
13. Banh KV, James S, Hendey GW, et al. Single-dose etomidate for intubation in the trauma patient. J Emerg Med 2012; 43:e277-e282.
14. Filanovsky Y, Miller P, Kao J. Myth: ketamine should not be used as an induction agent for intubation in patients with head injury. CJEM 2010; 12:154-157.
15. Bernhard M, Matthes G, Kanz KG, et al. Emergency anesthesia, airway management and ventilation in major trauma. Background and key messages of the interdisciplinary S3 guidelines for major trauma patients. Anaesthesist 2011; 60:1027-1040.
16. Gomez-Sanchez CE. Adrenal dysfunction in critically ill patients. N Engl J Med 2013.
17. Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013; 368:1477-1488.
18. Molenaar N, Bijkerk RM, Beishuizen A, et al. Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate. Crit Care 2012; 16:R121.
19. McPhee LC, Badawi O, Fraser GL, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database*. Crit Care Med 2013; 41:774-783.
20. Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med 2012; 40:2945-2953.
21. Pearl RG. Review: etomidate increased mortality and adrenal insufficiency in adults with sepsis. Ann Intern Med 2013; 158:JC2-JC10.
22. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 2011; 37:901-910.
23. Cuthbertson BH, Sprung CL, Annane D, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35:1868-1876.
24. Payen JF, Dupuis C, Trouve-Buisson T, et al. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 2012; 40:29-35.
25. Dmello D. Supplemental corticosteroids after intubation using etomidate in severe sepsis and septic shock. Crit Care Med 2012; 40:2003-2004.
26. Lauzier F, Turgeon AF. Etomidate: buy now, pay later?*. Crit Care Med 2012; 40:3086-3087.
27. Sneyd Jr. Novel etomidate derivatives. Curr Pharm Des 2012; 18:6253-6256.